eMedicine Specialties > Dermatology > Diseases of the Oral Mucosa

Metastatic Neoplasms to the Oral Cavity: Differential Diagnoses & Workup

Author: Abraham Hirshberg, MD, DMD, Senior Lecturer, Department of Oral Pathology and Oral Medicine, School of Dental Medicine, Tel Aviv University, Israel
Coauthor(s): Amos Buchner, DMD, MSD, Chairman, Professor, Department of Oral Pathology and Oral Medicine, Tel Aviv University School of Dental Medicine, Israel
Contributor Information and Disclosures

Updated: Mar 28, 2008

Differential Diagnoses

Malignant Melanoma
Pyogenic Granuloma (Lobular Capillary Hemangioma)
Oral Fibromas and Fibromatoses
Squamous Cell Carcinoma
Oral Malignant Melanoma
Oral Pyogenic Granuloma
Peripheral Giant Cell Granuloma

Other Problems to Be Considered

Oral soft tissues
Pyogenic granuloma
Peripheral giant cell granuloma (only in the gingiva)
Fibrous epulis (only in the gingiva)
Malignant primary tumor (oral cancer, including salivary gland tumor)

Jawbone (differential diagnosis depends on location)
Malignant tumors (eg, primary intraosseous carcinoma, other malignant odontogenic tumors)
Central malignant salivary gland tumors
Sarcoma (eg, malignant fibrous histiocytoma, fibrosarcoma)

Bony lesion can mimic benign lesion (some cases)
Periapical pathology
Infected odontogenic cyst or tumor
Osteomyelitis

Workup

Imaging Studies

  • The balance between the activities of osteoblasts and osteoclasts in general determines the phenotype of metastatic bone lesions, either osteolytic or osteoblastic. Metastases from prostate cancer nearly always form osteoblastic lesions in bone7 ; by contrast, bone metastases from kidney, lung, or breast cancers are more often osteolytic.
    • The most common radiographic presentation is that of a lytic lesion with ill-defined margins.
    • Occasional osteoblastic lesions are observed.
    • In approximately 5% of the patients, the radiographs do not reveal any pathologic changes.
  • An oral radiography survey may be helpful.
  • Periapical and panoramic radiographs, CT scans, and MRIs can be obtained to evaluate the extent of the lesion.
  • Lack of radiographic changes does not exclude the possible presence of a small metastatic deposit in the jawbone.

Procedures

  • The following steps constitute the diagnostic algorithm for evaluation of oral metastases:
    • Review the clinical history.
    • Review the available radiographic findings.
    • If a history of a previous tumor exists, obtain the slides and reports for review.
    • Perform a biopsy of the lesion.
    • Evaluate the light microscopic features of the neoplasm. On the basis of the histologic features, determine the need for special studies (eg, histochemical staining, immunohistochemical tests, electron microscopy).
    • In cases in which the primary tumor is not found (unknown primary), look for signs and symptoms in an attempt to identify the potential primary. This can be accomplished with a complete history and physical examination, with special attention to the breast, rectal, and pelvic examination findings.
      • The standard battery of laboratory tests includes a complete blood cell count, liver function tests, calcium level, urinalysis, and serum creatinine value. A chest radiograph is also always indicated. Chest radiographs and chest CT scans have proven to be useful in the detection of primary lung tumors.
      • Sex-specific tests include serum prostate-specific antigen assay and transrectal ultrasound for male patients and mammography and cervical Papanicolaou test (Pap smear) for female patients.
      • Additionally, a CT scan of the abdomen and pelvis has been used in some series; it has been shown to identify the primary tumor in 10-35% of patients. A CT scan can identify primary tumors in the pancreas, liver, adrenals, kidney, gallbladder, ovaries, and stomach.
      • Positron electron transmission scanning with fluorodeoxyglucose is rapidly gaining favor in the evaluation of unknown primary cancers, particularly in instances in which other image modalities have failed to identify a source.
    • Plan the treatment protocol based on the clinical, pathological, and radiographic information.

Histologic Findings

The diagnosis is always based on histologic findings in the biopsy specimen. The clue to the diagnosis is the resemblance of the metastasis to the primary tumor. If a history of a previous tumor exists, compare the current histologic findings with those of the preexisting primary malignant tumor. In some cases, histochemical staining, immunohistochemical tests, and electron microscopy should be performed to identify the primary source of the metastatic tumor.

Attend to the differentiation of the primary intraoral malignancies from metastatic tumors. Several primary intraoral malignancies (especially those originating from salivary glands) have histologic features similar to those of tumors in distant organs: for example, primary ductal carcinoma of a salivary gland origin versus metastatic breast carcinoma, primary intraoral clear cell carcinoma versus metastatic renal cell carcinoma, primary intraoral squamous cell carcinoma versus metastatic squamous cell carcinoma from the lung, or primary intraoral malignant melanoma versus metastatic malignant melanoma. Malignant soft tissue tumors may originate intraorally, but, because of their rarity, one should always consider a metastatic origin.

More on Metastatic Neoplasms to the Oral Cavity

Overview: Metastatic Neoplasms to the Oral Cavity
Differential Diagnoses & Workup: Metastatic Neoplasms to the Oral Cavity
Treatment & Medication: Metastatic Neoplasms to the Oral Cavity
Follow-up: Metastatic Neoplasms to the Oral Cavity
Multimedia: Metastatic Neoplasms to the Oral Cavity
References

References

  1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. Jan 1995;1(1):27-31. [Medline].

  2. Dai CY, Haqq CM, Puzas JE. Molecular correlates of site-specific metastasis. Semin Radiat Oncol. Apr 2006;16(2):102-10. [Medline].

  3. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. Jul 2004;4(7):540-50. [Medline].

  4. Pires FR, Sagarra R, Corrêa ME, Pereira CM, Vargas PA, Lopes MA. Oral metastasis of a hepatocellular carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Mar 2004;97(3):359-68. [Medline].

  5. Whitaker B, Robinson K, Hewan-Lowe K, Budnick S. Thyroid metastasis to the oral soft tissues: case report of a diagnostic dilemma. J Oral Maxillofac Surg. May 1993;51(5):588-93. [Medline].

  6. Laurencet FM, Anchisi S, Tullen E, Dietrich PY. Mental neuropathy: report of five cases and review of the literature. Crit Rev Oncol Hematol. Apr 2000;34(1):71-9. [Medline].

  7. Logothetis CJ, Lin SH. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer. Jan 2005;5(1):21-8. [Medline].

  8. Chorost MI, Lee MC, Yeoh CB, Molina M, Ghosh BC. Unknown primary. J Surg Oncol. Sep 15 2004;87(4):191-203. [Medline].

  9. Dennis JL, Oien KA. Hunting the primary: novel strategies for defining the origin of tumours. J Pathol. Jan 2005;205(2):236-47. [Medline].

  10. Eccles SA. Targeting key steps in metastatic tumour progression. Curr Opin Genet Dev. Feb 2005;15(1):77-86. [Medline].

  11. Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview. Eur J Cancer B Oral Oncol. Nov 1995;31B(6):355-60. [Medline].

  12. Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med. Oct 1993;22(9):385-90. [Medline].

  13. Hirshberg A, Leibovich P, Buchner A. Metastatic tumors to the jawbones: analysis of 390 cases. J Oral Pathol Med. Sep 1994;23(8):337-41. [Medline].

  14. Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity - Pathogenesis and analysis of 673 cases. Oral Oncol. Dec 3 2007;[Medline].

  15. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. Jun 2006;6(6):449-58. [Medline].

  16. Raubenheimer EJ, Noffke CE. Pathogenesis of bone metastasis: a review. J Oral Pathol Med. Mar 2006;35(3):129-35. [Medline].

  17. Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?. Cancer Res. Jul 15 2005;65(14):5991-5; discussion 5995. [Medline].

  18. van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg. Feb 2003;41(1):3-6. [Medline].

  19. Yokota J. Tumor progression and metastasis. Carcinogenesis. Mar 2000;21(3):497-503. [Medline].

  20. Zachariades N. Neoplasms metastatic to the mouth, jaws and surrounding tissues. J Craniomaxillofac Surg. Aug 1989;17(6):283-90. [Medline].

Further Reading

Keywords

metastatic tumors to the oral cavity, metastatic tumors to the jaws, metastatic tumors to the oral mucosa, mouth cancer

Contributor Information and Disclosures

Author

Abraham Hirshberg, MD, DMD, Senior Lecturer, Department of Oral Pathology and Oral Medicine, School of Dental Medicine, Tel Aviv University, Israel
Abraham Hirshberg, MD, DMD is a member of the following medical societies: American Academy of Oral and Maxillofacial Pathology, International Association for Dental Research, and International Association of Oral Pathologists
Disclosure: Nothing to disclose.

Coauthor(s)

Amos Buchner, DMD, MSD, Chairman, Professor, Department of Oral Pathology and Oral Medicine, Tel Aviv University School of Dental Medicine, Israel
Amos Buchner, DMD, MSD is a member of the following medical societies: American Academy of Oral and Maxillofacial Pathology, American Academy of Oral Medicine, International Association for Dental Research, and International Association of Oral Pathologists
Disclosure: Nothing to disclose.

Medical Editor

Sungnack Lee, MD, Vice President of Medical Affairs, Professor, Department of Dermatology, Ajou University School of Medicine, Korea
Sungnack Lee, MD is a member of the following medical societies: American Dermatological Association
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati
Drore Eisen, MD, DDS is a member of the following medical societies: American Academy of Dermatology, American Academy of Oral Medicine, and American Dental Association
Disclosure: Nothing to disclose.

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.